SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Sick Visit — Mahalia Jackson

PatientMahalia Jackson
Date of birth1973-10-26
IdentifiersMRN HR-ML035-SYN; SSN (made up) 000-35-4692
Document date2026-06-15
AuthorBeatrice Fontenot, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Hoarse voice and sore throat for three days, with a concert in four days. [S]

History of Present Illness

Ms. Jackson called on Monday and was seen the same day. A cold began five days ago, after a weekend of two concerts and a church service; for three days her voice has been hoarse and breaks on high notes, her throat is sore, and she has a mild dry cough. Her highest temperature at home was 37.5 °C. She has no breathlessness beyond her usual, no chest pain, no palpitations, and no shocks from her defibrillator. She takes prednisone 20 mg each morning, methotrexate 20 mg on Sundays with folic acid daily, atovaquone, metoprolol, alendronate and vitamin D, and has missed no doses. She has a concert on Friday and is worried about singing through it. She has had no thoughts of self-harm. [S]

ElementDetail
OnsetCold five days ago; hoarseness for three days
VoiceHoarse; breaks on high notes; speaking voice tires by evening
TemperatureHighest 37.5 °C at home; 37.4 °C today
ContextOn prednisone 20 mg daily and methotrexate 20 mg weekly; a concert in four days
Associated signs and symptomsSore throat and dry cough; no breathlessness beyond her usual, chest pain, palpitations, device shocks, or thoughts of self-harm

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever of 38.0 °C or more, chills or night sweats
Ears, nose, mouth, and throatPositiveHoarseness, sore throat and a runny nose; no mouth sores, white patches or ear pain
RespiratoryPositiveMild dry cough; breathing no worse than her usual; no wheeze
CardiovascularNegativeNo chest pain, palpitations or device shocks
PsychiatricNegativeWorried about the concert; no thoughts of self-harm

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Prednisone 20 mg oral tablet, two tablets (40 mg) by mouth each morning40 mg each morningOral route2026-03-09 to 2026-05-11completedS
Prednisone 10 mg oral tablet, three tablets (30 mg) by mouth each morning for four weeks30 mg each morning for four weeksOral route2026-05-11 to 2026-06-08completedS
Prednisone 20 mg oral tablet, one tablet (20 mg) by mouth each morning for four weeks20 mg each morning for four weeksOral route2026-06-08 to 2026-07-06completedS
Methotrexate 2.5 mg oral tablet, six tablets (15 mg) by mouth once a week on Sundays15 mg once weeklyOral route2026-03-09 to 2026-05-11completedS
Methotrexate 2.5 mg oral tablet, eight tablets (20 mg) by mouth once a week on Sundays20 mg once weeklyOral route2026-05-11activeS
Folic acid 1 mg oral tablet, one tablet by mouth dailyOne tablet dailyOral route2026-03-09activeS
Atovaquone 750 mg/5 mL oral suspension, 1500 mg (10 mL) by mouth once daily with food1500 mg once daily with foodOral route2026-03-09 to 2026-07-06completedS
Alendronate 70 mg oral tablet, one tablet by mouth once weekly on rising, with a full glass of water, staying upright for 30 minutesOne tablet once weeklyOral route2026-03-16activeS
Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth dailyOne tablet dailyOral route2026-03-09activeS
Cholecalciferol (vitamin D3) 25 mcg (1000 units) oral tablet, one tablet by mouth dailyOne tablet dailyOral route2026-05-11activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-06-15Body height170cmS
2026-06-15Body weight93.4kgS
2026-06-15Body mass index (BMI) [Ratio]32.3kg/m2S
2026-06-15Systolic blood pressure134mm[Hg]S
2026-06-15Diastolic blood pressure84mm[Hg]S
2026-06-15Heart rate72/minS
2026-06-15Respiratory rate16/minS
2026-06-15Body temperature37.4CelS
2026-06-15Oxygen saturation in Arterial blood by Pulse oximetry97%S

Physical Exam

Vital signs recorded on 2026-06-15; see the Vital Signs section. [S]

SystemFinding
GeneralWell; hoarse, breathy voice; temperature 37.4 °C, pulse 72, blood pressure 134/84, oxygen saturation 97 percent on room air
Head, eyes, ears, nose, and throatMildly red throat without exudate; no thrush on the tongue, palate or throat; clear nasal discharge; ear drums normal
NeckNo tender or enlarged nodes; no stridor
RespiratoryClear to auscultation; no crackles or wheeze
CardiovascularRegular rhythm; defibrillator pocket healed

Problems

ProblemClinical statusVerificationCodeProvenance
Breathlessness on exertion and a dry cough for three months, worse on tour, with tiredness and chest tightness; she can no longer hold long phrases; bilateral hilar lymph node enlargement on today's chest radiograph; granulomas were reported at an abdominal operation twelve years ago, with no pathology report available: sarcoidosis must be confirmed by tissue and other causes excludedresolvedconfirmed R06.09S — Synthetic presenting problem anchored to the documented breathlessness during performances and the 1952 granulomas. Superseded by the tissue diagnosis at the consultation.
Palpitations with two spells of light-headedness while singing; ECG today: sinus rhythm with first-degree atrioventricular block (PR 240 ms) and frequent ventricular ectopic beats: cardiac involvement must be looked forresolvedconfirmed R00.2S — Synthetic finding; superseded when cardiac sarcoidosis was diagnosed.
Hypercalcemia: calcium 10.8 mg/dL with a high 1,25-dihydroxyvitamin D and a low 25-hydroxyvitamin D, while taking an over-the-counter calcium and vitamin D supplement; creatinine slightly raisedresolvedconfirmed E83.52S — Synthetic finding; resolved on treatment.
Pulmonary sarcoidosis with hilar and mediastinal lymph node involvement (Scadding stage II), confirmed by non-necrotizing granulomas on EBUS-guided lymph node aspiration with negative stains and cultures; mild restriction and reduced diffusing capacity; synthetic modern detail linked to her documented sarcoidosisactiveconfirmed D86.2S — Synthetic histology, stage and lung function; her biographer reports a diagnosis of sarcoidosis after granulomas were found at an operation (D, probable).
Acute viral laryngitis: three days of hoarseness, a sore throat and a mild dry cough after a cold, without fever, on prednisone 20 mg and methotrexate; rapid influenza and COVID-19 tests negative; no thrush; resolvedactiveconfirmed J04.0S — Synthetic acute infection; not a historical claim.
Cardiac sarcoidosis: first-degree atrioventricular block, ventricular ectopy (6 percent of beats) with nonsustained ventricular tachycardia, left ventricular ejection fraction 47 percent, patchy late gadolinium enhancement of the basal septum and inferolateral wall, and matching focal FDG uptake on PET; synthetic modern detail linked to the documented private account that sarcoidosis was in her heartactiveconfirmed D86.85S — Synthetic cardiac findings; the account that her doctors told her sarcoidosis was in her heart rests on her biographer (D, probable), and the interpretation of her later heart disease is R.
Long-term systemic glucocorticoid treatment for sarcoidosis, with bone, glucose, blood pressure, infection and eye risks to manageactiveconfirmed Z79.52S — Synthetic treatment status.
Dual-chamber implantable cardioverter-defibrillator, placed after sustained monomorphic ventricular tachycardia was induced at electrophysiology study; remote monitoringactiveconfirmed Z95.810S — Synthetic device status after the synthetic implant.

Assessment and Plan

Guideline basis: Baughman RP, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J 2021;58(6):2004079 (PMID 34140301) (2021); Stachler RJ, et al. Clinical Practice Guideline: Hoarseness (Dysphonia) (Update). Otolaryngol Head Neck Surg 2018;158(1_suppl):S1-S42 (PMID 29494321) (2018)

Follow-up: Phone check in three days. Return if hoarseness lasts beyond four weeks or for fever, breathlessness or chest pain. Next planned review in August with the repeat FDG-PET. Next scheduled visit 2026-08-24: six months of treatment: repeat FDG-PET, steroid taper, and plans for touring. [S]